Disruptions in the realm of medical science

von Rathmell, W. Kimryn
Veröffentlicht in J Clin Invest (2020)

VHL Inactivation in Renal Cell Carcinoma: Implications for Diagnosis, Prognosis, and Treatment

von Rathmell, W. Kimryn, Chen, Shufen
Veröffentlicht 2008

Systematic Review: ClearCode 34 – A Validated Prognostic Signature in Clear Cell Renal Cell Carcinoma (ccRCC)

von Ghatalia, Pooja, Rathmell, W. Kimryn
Veröffentlicht in Kidney Cancer (2018)

The 2019 Nobel Prize honors fundamental discoveries in hypoxia response

von Moslehi, Javid, Rathmell, W. Kimryn
Veröffentlicht in J Clin Invest (2019)

Identification of Ror2 as a Hypoxia-inducible Factor Target in von Hippel-Lindau-associated Renal Cell Carcinoma

von Wright, Tricia M., Rathmell, W. Kimryn
Veröffentlicht 2010

Using Molecular Biology to Develop Drugs for Renal Cell Carcinoma

von Cowey, C. Lance, Rathmell, W. Kimryn
Veröffentlicht 2008

Renal Cell Carcinoma: Where Will the State-of-the-Art Lead Us?

von Brannon, A. Rose, Rathmell, W. Kimryn
Veröffentlicht 2010

Recent Updates in Renal Cell Carcinoma

von Rathmell, W. Kimryn, Godley, Paul A
Veröffentlicht 2010

VHL Gene Mutations in Renal Cell Carcinoma: Role as a Biomarker of Disease Outcome and Drug Efficacy

von Cowey, C. Lance, Rathmell, W. Kimryn
Veröffentlicht 2009

Emerging molecular classification in RCC: implications for drug development

von Hacker, Kathryn E., Rathmell, W. Kimryn
Veröffentlicht 2010

Seeing the forest for the trees: kidney oncogenomes relate to therapeutic outcomes

von Chism, David D., Rathmell, W. Kimryn
Veröffentlicht 2014

Rest Assured, much can be learned from adjuvant studies in renal cancer

von Chism, David D., Rathmell, W. Kimryn
Veröffentlicht in Nat Rev Nephrol (2016)

A tale of two cancers: Complete genetic analysis of chromophobe renal cell carcinoma contrasts with clear cell renal cell carcinoma

von Fahey, Catherine C, Rathmell, W Kimryn
Veröffentlicht in Mol Cell Oncol (2015)

Renal Cancer Subtypes: Should We Be Lumping or Splitting for Therapeutic Decision Making?

von Haake, Scott M., Rathmell, W. Kimryn
Veröffentlicht in Cancer (2016)

Untangling ccRCC prognosis with SLINKY

von Reinfeld, Bradley I., Rathmell, W. Kimryn
Veröffentlicht in Oncotarget (2017)

COVID-19 impact on early career investigators: a call for action

von Levine, Ross L., Rathmell, W. Kimryn
Veröffentlicht in Nat Rev Cancer (2020)

Beyond Glycolysis: Hypoxia Signaling as a Master Regulator of Alternative Metabolic Pathways and the Implications in Clear Cell Renal Cell Carcinoma

von Bacigalupa, Zachary A., Rathmell, W. Kimryn
Veröffentlicht in Cancer Lett (2020)

Pushing the boundaries with collision collaboration: the marriage of ideas

von Rathmell, Jeffrey C., Rathmell, W. Kimryn
Veröffentlicht in J Clin Invest (2021)

Renal cell carcinoma

von Jonasch, Eric, Gao, Jianjun, Rathmell, W Kimryn
Veröffentlicht in BMJ (2014)

Clear cell renal cell carcinoma ontogeny and mechanisms of lethality

von Jonasch, Eric, Walker, Cheryl Lyn, Rathmell, W. Kimryn
Veröffentlicht in Nat Rev Nephrol (2020)